Safety of a Single Dose of Moxidectin Compared With Ivermectin in Individuals Living in Onchocerciasis Endemic Areas
Condition:   Onchocerciasis Interventions:   Drug: Moxidectin;   Drug: Ivermectin Sponsor:   Medicines Development for Global Health Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 17, 2020 Category: Research Source Type: clinical trials

Safety and Efficacy of IDA for Onchocerciasis
Condition:   Onchocerciasis Interventions:   Drug: IVM w/ ALB;   Drug: Single dose of IDA;   Drug: Three daily doses of IDA Sponsors:   Washington University School of Medicine;   Case Western Reserve University;   University of Health and Allied Sciences Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 5, 2019 Category: Research Source Type: clinical trials

Clinical Trial Evaluating the Safety and Efficacy of Moxidectin 2 mg Ivermectin-controlled in Loa Loa Microfilaremic Patients
Conditions:   Onchocerciasis, Ocular;   Loiasis Interventions:   Drug: Moxidectin 2 MG Oral Tablet;   Drug: Ivermectin 3Mg Tab;   Drug: Placebo oral tablet Sponsor:   Institut National de la Santé Et de la Recherche Médicale, France Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Clinical Trial Evaluating the Safety and Efficacy of Levamisole in Loa Loa Microfilaremic Patients
Conditions:   Onchocerciasis, Ocular;   Loiasis Interventions:   Drug: LEV 1 mg/kg;   Drug: LEV 1,5 mg/kg;   Drug: Placebo Sponsor:   Institut National de la Santé Et de la Recherche Médicale, France Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Clinical Trial Evaluating the Safety and Efficacy of Moxidectin 2 mg Ivermectin-controlled in Loa Loa Microfilaremic Patients
Conditions:   Onchocerciasis, Ocular;   Loiasis Interventions:   Drug: Moxidectin 2 MG Oral Tablet;   Drug: Ivermectin 3Mg Tab;   Drug: Placebo oral tablet Sponsor:   Institut National de la Santé Et de la Recherche Médicale, France Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Clinical Trial Evaluating the Safety and Efficacy of Levamisole in Loa Loa Microfilaremic Patients
Conditions:   Onchocerciasis, Ocular;   Loiasis Interventions:   Drug: LEV 1 mg/kg;   Drug: LEV 1,5 mg/kg;   Drug: Placebo Sponsor:   Institut National de la Santé Et de la Recherche Médicale, France Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Clinical Trial Evaluating the Safety and Efficacy of Moxidectin 2 mg Ivermectin-controlled in Loa Loa Microfilaremic Patients
Conditions:   Onchocerciasis, Ocular;   Loiasis Interventions:   Drug: Moxidectin 2 MG Oral Tablet;   Drug: Ivermectin 3Mg Tab;   Drug: Placebo oral tablet Sponsor:   Institut National de la Santé Et de la Recherche Médicale, France Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Clinical Trial Evaluating the Safety and Efficacy of Levamisole in Loa Loa Microfilaremic Patients
Conditions:   Onchocerciasis, Ocular;   Loiasis Interventions:   Drug: LEV 1 mg/kg;   Drug: LEV 1,5 mg/kg;   Drug: Placebo Sponsor:   Institut National de la Santé Et de la Recherche Médicale, France Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Clinical Trial Evaluating the Safety and Efficacy of Moxidectin 2 mg Ivermectin-controlled in Loa Loa Microfilaremic Patients
Conditions:   Onchocerciasis, Ocular;   Loiasis Interventions:   Drug: Moxidectin 2 MG Oral Tablet;   Drug: Ivermectin 3Mg Tab;   Drug: Placebo oral tablet Sponsor:   Institut National de la Santé Et de la Recherche Médicale, France Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Clinical Trial Evaluating the Safety and Efficacy of Levamisole in Loa Loa Microfilaremic Patients
Conditions:   Onchocerciasis, Ocular;   Loiasis Interventions:   Drug: LEV 1 mg/kg;   Drug: LEV 1,5 mg/kg;   Drug: Placebo Sponsor:   Institut National de la Santé Et de la Recherche Médicale, France Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Clinical Trial Evaluating the Safety and Efficacy of Moxidectin 2 mg Ivermectin-controlled in Loa Loa Microfilaremic Patients
Conditions:   Onchocerciasis, Ocular;   Loiasis Interventions:   Drug: Moxidectin 2 MG Oral Tablet;   Drug: Ivermectin 3Mg Tab;   Drug: Placebo oral tablet Sponsor:   Institut National de la Santé Et de la Recherche Médicale, France Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Clinical Trial Evaluating the Safety and Efficacy of Levamisole in Loa Loa Microfilaremic Patients
Conditions:   Onchocerciasis, Ocular;   Loiasis Interventions:   Drug: LEV 1 mg/kg;   Drug: LEV 1,5 mg/kg;   Drug: Placebo Sponsor:   Institut National de la Santé Et de la Recherche Médicale, France Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Clinical Trial Evaluating the Safety and Efficacy of Moxidectin 2 mg Ivermectin-controlled in Loa Loa Microfilaremic Patients
Conditions:   Onchocerciasis, Ocular;   Loiasis Interventions:   Drug: Moxidectin 2 MG Oral Tablet;   Drug: Ivermectin 3Mg Tab;   Drug: Placebo oral tablet Sponsor:   Institut National de la Santé Et de la Recherche Médicale, France Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Clinical Trial Evaluating the Safety and Efficacy of Levamisole in Loa Loa Microfilaremic Patients
Conditions:   Onchocerciasis, Ocular;   Loiasis Interventions:   Drug: LEV 1 mg/kg;   Drug: LEV 1,5 mg/kg;   Drug: Placebo Sponsor:   Institut National de la Santé Et de la Recherche Médicale, France Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Clinical Trial Evaluating the Safety and Efficacy of Moxidectin 2 mg Ivermectin-controlled in Loa Loa Microfilaremic Patients
Conditions:   Onchocerciasis, Ocular;   Loiasis Interventions:   Drug: Moxidectin 2 MG Oral Tablet;   Drug: Ivermectin 3Mg Tab;   Drug: Placebo oral tablet Sponsor:   Institut National de la Santé Et de la Recherche Médicale, France Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Clinical Trial Evaluating the Safety and Efficacy of Levamisole in Loa Loa Microfilaremic Patients
Conditions:   Onchocerciasis, Ocular;   Loiasis Interventions:   Drug: LEV 1 mg/kg;   Drug: LEV 1,5 mg/kg;   Drug: Placebo Sponsor:   Institut National de la Santé Et de la Recherche Médicale, France Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Clinical Trial Evaluating the Safety and Efficacy of Moxidectin 2 mg Ivermectin-controlled in Loa Loa Microfilaremic Patients
Conditions:   Onchocerciasis, Ocular;   Loiasis Interventions:   Drug: Moxidectin 2 MG Oral Tablet;   Drug: Ivermectin 3Mg Tab;   Drug: Placebo oral tablet Sponsor:   Institut National de la Santé Et de la Recherche Médicale, France Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Clinical Trial Evaluating the Safety and Efficacy of Levamisole in Loa Loa Microfilaremic Patients
Conditions:   Onchocerciasis, Ocular;   Loiasis Interventions:   Drug: LEV 1 mg/kg;   Drug: LEV 1,5 mg/kg;   Drug: Placebo Sponsor:   Institut National de la Santé Et de la Recherche Médicale, France Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Clinical Trial Evaluating the Safety and Efficacy of Moxidectin 2 mg Ivermectin-controlled in Loa Loa Microfilaremic Patients
Conditions:   Onchocerciasis, Ocular;   Loiasis Interventions:   Drug: Moxidectin 2 MG Oral Tablet;   Drug: Ivermectin 3Mg Tab;   Drug: Placebo oral tablet Sponsor:   Institut National de la Santé Et de la Recherche Médicale, France Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Clinical Trial Evaluating the Safety and Efficacy of Levamisole in Loa Loa Microfilaremic Patients
Conditions:   Onchocerciasis, Ocular;   Loiasis Interventions:   Drug: LEV 1 mg/kg;   Drug: LEV 1,5 mg/kg;   Drug: Placebo Sponsor:   Institut National de la Santé Et de la Recherche Médicale, France Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Clinical Trial Evaluating the Safety and Efficacy of Moxidectin 2 mg Ivermectin-controlled in Loa Loa Microfilaremic Patients
Conditions:   Onchocerciasis, Ocular;   Loiasis Interventions:   Drug: Moxidectin 2 MG Oral Tablet;   Drug: Ivermectin 3Mg Tab;   Drug: Placebo oral tablet Sponsor:   Institut National de la Santé Et de la Recherche Médicale, France Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Clinical Trial Evaluating the Safety and Efficacy of Levamisole in Loa Loa Microfilaremic Patients
Conditions:   Onchocerciasis, Ocular;   Loiasis Interventions:   Drug: LEV 1 mg/kg;   Drug: LEV 1,5 mg/kg;   Drug: Placebo Sponsor:   Institut National de la Santé Et de la Recherche Médicale, France Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Clinical Trial Evaluating the Safety and Efficacy of Moxidectin 2 mg Ivermectin-controlled in Loa Loa Microfilaremic Patients
Conditions:   Onchocerciasis, Ocular;   Loiasis Interventions:   Drug: Moxidectin 2 MG Oral Tablet;   Drug: Ivermectin 3Mg Tab;   Drug: Placebo oral tablet Sponsor:   Institut National de la Santé Et de la Recherche Médicale, France Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Clinical Trial Evaluating the Safety and Efficacy of Levamisole in Loa Loa Microfilaremic Patients
Conditions:   Onchocerciasis, Ocular;   Loiasis Interventions:   Drug: LEV 1 mg/kg;   Drug: LEV 1,5 mg/kg;   Drug: Placebo Sponsor:   Institut National de la Santé Et de la Recherche Médicale, France Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Clinical Trial Evaluating the Safety and Efficacy of Moxidectin 2 mg Ivermectin-controlled in Loa Loa Microfilaremic Patients
Conditions:   Onchocerciasis, Ocular;   Loiasis Interventions:   Drug: Moxidectin 2 MG Oral Tablet;   Drug: Ivermectin 3Mg Tab;   Drug: Placebo oral tablet Sponsor:   Institut National de la Santé Et de la Recherche Médicale, France Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Clinical Trial Evaluating the Safety and Efficacy of Levamisole in Loa Loa Microfilaremic Patients
Conditions:   Onchocerciasis, Ocular;   Loiasis Interventions:   Drug: LEV 1 mg/kg;   Drug: LEV 1,5 mg/kg;   Drug: Placebo Sponsor:   Institut National de la Santé Et de la Recherche Médicale, France Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Evaluation of the Diagnosis Performances of DEC LTS-2 Skin Patch for Onchocerciasis in Central Africa
Conditions:   Onchocerciasis;   Loiasis;   Diagnoses Disease;   Neglected Diseases Interventions:   Diagnostic Test: LTS-2 DEC patch;   Diagnostic Test: Skin snips Sponsor:   Institut National de la Santé Et de la Recherche Médicale, France Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 29, 2019 Category: Research Source Type: clinical trials